iLof
Generated by Meeveem AI
"Accelerating personalised medicine through AI-powered optical biomarker discovery"
London
•11 - 50 Employees
•Diagnostics
About iLof
iLoF pioneers an AI-powered photonics platform that transforms blood samples into optical fingerprints, creating a digital library of disease biomarkers. Using only microlitres of blood and light, the platform screens and stratifies patients for clinical trials in under 10 seconds, without consumables or invasive procedures. The platform delivers measurable impact for drug developers: 40% cost savings, 70% faster screening, and higher quality candidate pools that improve trial outcomes. Initially focused on Alzheimer's disease, iLoF is expanding its virtual fingerprint library to cancer and complex diseases where precise patient stratification accelerates personalised treatments.
22
Team Members
2019
Founded
Diagnostics
Sector
Hybrid
Work Environment
Our Vision
A world where every disease has a digital biomarker fingerprint, enabling truly personalised medicine for millions of patients globally.
Our Mission
At iLoF, our mission is to accelerate the future of personalised drug discovery and development through breakthrough AI-powered photonics technology.